UCLA Health’s Jonsson Comprehensive Cancer Center is recognized by NCI and provides a multidisciplinary approach to cancer care. Some successful targeted therapies were developed in part by UCLA such as Herceptin, Gleevec, and Sprycel. The center has more than 350 physicians and scientists and encourages close collaboration among these different experts.






